Sridevi Devaraj - Concepedia

Author

Sridevi Devaraj

University of California Davis Medical Center ORCID

Also Known As

Amsterdam Dallinga-Thie, Devaraj, S., G Boston, S DEVARAJ, S Devaraj, S. Devaraj, SRIDEVI DEVARAJ, Sankari Jai Devaraj, Sridevi Devaraj, Sridevi Devaraj, PhD

462

Publications

21.2K

Citations

H-Index

219

Concepts

All Affiliations

University of California Davis Medical Center Baylor College of Medicine Texas Children's Hospital The University of Texas Southwestern Medical Center University of California, Davis

About

Sridevi Devaraj is an author at University of California Davis Medical Center specializing in medicine, inflammation, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	48	88	6.7K
2	Health Sciences	18	23	1.7K
3	Education	1	1	26
4	Engineering	1	1	26
5	Natural Sciences	1	1	13

Sridevi Devaraj

187

Publications

17.2K

Citations

H-Index

Page 1

	Year	Citations
Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells Senthil Kumar Venugopal, Sridevi Devaraj, Ivan S. Yuhanna, Circulation	2002	855
Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels Ishwarlal Jialal, Daniel T. Stein, David S. Balis, Circulation	2001	731
C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells Sridevi Devaraj, Dan Xu, Ishwarlal Jialal Circulation	2003	646
Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects Mohan R. Dasu, Sridevi Devaraj, Samuel Park, Diabetes Care	2010	567
High Glucose Induces Toll-Like Receptor Expression in Human Monocytes Mohan R. Dasu, Sridevi Devaraj, Ling Zhao, Diabetes	2008	438
Increased Toll-Like Receptor (TLR) 2 and TLR4 Expression in Monocytes from Patients with Type 1 Diabetes: Further Evidence of a Proinflammatory State Sridevi Devaraj, Mohan R. Dasu, Jason Rockwood, The Journal of Clinical Endocrinology & Metabolism	2007	367
Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices John H. Contois, Joseph P. McConnell, Amar A Sethi, Clinical Chemistry	2009	325
Increased Monocytic Activity and Biomarkers of Inflammation in Patients With Type 1 Diabetes Sridevi Devaraj, Nicole Glaser, S. Griffen, Diabetes Monocytic ActivityImmunologyInflammationMetabolic SyndromeType 1	2006	289
Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Subodh Verma, Sridevi Devaraj, Ishwarlal Jialal PubMed InflammationThrombosisVascular DiseaseCardiovascular DiseaseProatherogenic Culprit	2006	251
Antioxidant supplementation prevents exercise-induced lipid peroxidation, but not inflammation, in ultramarathon runners Angela Mastaloudis, Jason D. Morrow, Dawn W Hopkins, Free Radical Biology and Medicine InflammationPhysical ActivityKinesiologyUltramarathon RunnersExercise	2004	246

Page 1